Literature DB >> 2668680

Analyzing a portion of the ROC curve.

D K McClish1.   

Abstract

The area under the ROC curve is a common index summarizing the information contained in the curve. When comparing two ROC curves, though, problems arise when interest does not lie in the entire range of false-positive rates (and hence the entire area). Numerical integration is suggested for evaluating the area under a portion of the ROC curve. Variance estimates are derived. The method is applicable for either continuous or rating scale binormal data, from independent or dependent samples. An example is presented which looks at rating scale data of computed tomographic scans of the head with and without concomitant use of clinical history. The areas under the two ROC curves over an a priori range of false-positive rates are examined, as well as the areas under the two curves at a specific point.

Mesh:

Year:  1989        PMID: 2668680     DOI: 10.1177/0272989X8900900307

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  97 in total

Review 1.  ROC analysis in medical imaging: a tutorial review of the literature.

Authors:  Charles E Metz
Journal:  Radiol Phys Technol       Date:  2007-10-27

2.  Detection of mesial temporal lobe epileptiform discharges on intracranial electrodes using deep learning.

Authors:  Maurice Abou Jaoude; Jin Jing; Haoqi Sun; Claire S Jacobs; Kyle R Pellerin; M Brandon Westover; Sydney S Cash; Alice D Lam
Journal:  Clin Neurophysiol       Date:  2019-11-11       Impact factor: 3.708

3.  Comparison of analytical mathematical approaches for identifying key nuclear magnetic resonance spectroscopy biomarkers in the diagnosis and assessment of clinical change of diseases.

Authors:  Jason B Nikas; C Dirk Keene; Walter C Low
Journal:  J Comp Neurol       Date:  2010-10-15       Impact factor: 3.215

4.  Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer.

Authors:  Karen S Anderson; Sahar Sibani; Garrick Wallstrom; Ji Qiu; Eliseo A Mendoza; Jacob Raphael; Eugenie Hainsworth; Wagner R Montor; Jessica Wong; Jin G Park; Naa Lokko; Tanya Logvinenko; Niroshan Ramachandran; Andrew K Godwin; Jeffrey Marks; Paul Engstrom; Joshua Labaer
Journal:  J Proteome Res       Date:  2010-11-23       Impact factor: 4.466

5.  Estimation of haplotype associated with several quantitative phenotypes based on maximization of area under a receiver operating characteristic (ROC) curve.

Authors:  Shigeo Kamitsuji; Naoyuki Kamatani
Journal:  J Hum Genet       Date:  2006-02-15       Impact factor: 3.172

6.  Reliable and computationally efficient maximum-likelihood estimation of "proper" binormal ROC curves.

Authors:  Lorenzo L Pesce; Charles E Metz
Journal:  Acad Radiol       Date:  2007-07       Impact factor: 3.173

Review 7.  Looking back at prospective studies.

Authors:  Carolyn M Rutter
Journal:  Acad Radiol       Date:  2008-11       Impact factor: 3.173

8.  Exact confidence interval estimation for the difference in diagnostic accuracy with three ordinal diagnostic groups.

Authors:  Lili Tian; Chengjie Xiong; Chin-Ying Lai; Albert Vexler
Journal:  J Stat Plan Inference       Date:  2010-07-20       Impact factor: 1.111

9.  Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia.

Authors:  Lisa Mirabello; Mark Schiffman; Arpita Ghosh; Ana C Rodriguez; Natasa Vasiljevic; Nicolas Wentzensen; Rolando Herrero; Allan Hildesheim; Sholom Wacholder; Dorota Scibior-Bentkowska; Robert D Burk; Attila T Lorincz
Journal:  Int J Cancer       Date:  2012-08-20       Impact factor: 7.396

10.  Biceps skin-fold thickness may detect and predict early lipoatrophy in HIV-infected children.

Authors:  Steve Innes; Eva Schulte-Kemna; Mark F Cotton; Ekkehard Werner Zöllner; Richard Haubrich; Hartwig Klinker; Xiaoying Sun; Sonia Jain; Clair Edson; Margaret van Niekerk; Emily Ryan Innes; Helena Rabie; Sara H Browne
Journal:  Pediatr Infect Dis J       Date:  2013-06       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.